Lv1
30 积分 2025-04-11 加入
Targeting PI3K in Cancer Treatment: A Comprehensive Review with Insights from Clinical Outcomes
1天前
待确认
Chemoproteomic discovery of a covalent allosteric inhibitor of WRN helicase
7天前
已完结
The KRASG12C Inhibitor MRTX849 Provides Insight toward Therapeutic Susceptibility of KRAS-Mutant Cancers in Mouse Models and Patients
12天前
已完结
The European Federation for Medicinal Chemistry and Chemical Biology (EFMC) Best Practice Initiative: Hit to Lead
2个月前
已完结
Preclinical Assessment of the PI3Kα Selective Inhibitor Inavolisib and Prediction of Its Pharmacokinetics and Efficacious Dose in Human
2个月前
已完结
皖公网安备34019202002308
